Michael Golatta Selected Research

Michael Golatta Research Topics

47	Breast Neoplasms (Breast Cancer) 12/2022 - 12/2010
20	Neoplasms (Cancer) 12/2020 - 01/2011
6	Neoplasm Metastasis (Metastasis) 02/2022 - 01/2016
5	Pathologic Complete Response 10/2022 - 01/2018
3	Residual Neoplasm 02/2022 - 01/2016
2	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2022 - 08/2013
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 02/2022 - 02/2022
2	Pain (Aches) 10/2021 - 06/2015
2	Ovarian Neoplasms (Ovarian Cancer) 01/2016 - 06/2014
1	Male Breast Neoplasms (Male Breast Cancer) 12/2020
1	Neoplasm Micrometastasis 11/2020
1	Lymphatic Metastasis 12/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Contracture 01/2019
1	Dermatitis 01/2019
1	Hematoma 01/2019
1	Triple Negative Breast Neoplasms 12/2016
1	Carcinoma (Carcinomatosis) 03/2016
1	Ovarian Epithelial Carcinoma 01/2016
1	Carcinoma in Situ 01/2016
1	Spontaneous Fractures (Pathological Fracture) 01/2016
1	Fibroadenoma 06/2015
1	Cardiotoxicity 02/2014
1	Disease Progression 02/2014
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 08/2004
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2004

5	Hormones (Hormone)IBA 01/2019 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 12/2022 - 03/2016
4	Phenobarbital (Luminal)FDA Link 10/2022 - 01/2016
4	Estrogen ReceptorsIBA 01/2018 - 10/2012
2	Biological ProductsIBA 01/2022 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 03/2018 - 09/2016
2	AntigensIBA 12/2017 - 01/2016
2	human ERBB2 proteinIBA 12/2016 - 01/2016
2	Diphosphonates (Bisphosphonates)IBA 03/2016 - 01/2016
2	liposomal doxorubicin (Doxil)FDA Link 01/2016 - 02/2014
1	ErbB Receptors (EGF Receptor)IBA 10/2022
1	Tumor Biomarkers (Tumor Markers)IBA 03/2020
1	SiliconesIBA 01/2019
1	Collagenases (Collagenase)FDA Link 01/2019
1	Capsules (Microcapsules)IBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Amino Acids FDA Link 01/2019
1	Cell-Free Nucleic AcidsIBA 08/2017
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2017
1	Pamidronate (Aredia)FDA LinkGeneric 01/2016
1	AntibodiesIBA 01/2016
1	Clodronic Acid (Clodronate)IBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	Immunoglobulin M (IgM)IBA 01/2016
1	MucinsIBA 01/2016
1	PlatinumIBA 01/2016
1	1-dodecylpyridoxal (PLD)IBA 01/2016
1	Mucin-1 (CA 15-3 Antigen)IBA 01/2016
1	NitrogenIBA 06/2015
1	BRCA2 ProteinIBA 06/2014
1	Proteins (Proteins, Gene)FDA Link 06/2014
1	AsparagineIBA 06/2014
1	AnthracyclinesIBA 02/2014
1	Taxoids (Taxanes)IBA 02/2014
1	MicroRNAs (MicroRNA)IBA 01/2013
1	Ataxin-2IBA 08/2004
1	Ataxin-3IBA 08/2004

15	Neoadjuvant Therapy 10/2022 - 12/2016
11	Therapeutics 12/2022 - 01/2011
11	Segmental Mastectomy (Lumpectomy) 06/2022 - 12/2010
6	Radiotherapy 06/2022 - 01/2019
6	Lymph Node Excision (Lymph Node Dissection) 11/2020 - 09/2015
5	Drug Therapy (Chemotherapy) 02/2022 - 01/2018
5	Mastectomy (Mammectomy) 11/2020 - 11/2013
3	Adjuvant Radiotherapy 06/2022 - 01/2019
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 02/2022 - 10/2021
2	Brachytherapy 02/2022 - 02/2022
2	Adjuvant Chemotherapy 12/2020 - 01/2018
2	Mammaplasty (Breast Reconstruction) 01/2019 - 11/2013
2	Operative Surgical Procedures 12/2017 - 01/2016
2	Conservative Treatment 09/2015 - 01/2011
1	Palliative Care (Palliative Therapy) 02/2022
1	Surgical Instruments (Clip) 02/2022
1	Prophylactic Mastectomy 06/2017
1	Salvage Therapy 01/2016
1	Oral Administration 01/2016
1	Cryosurgery 06/2015
1	Modified Radical Mastectomy (Mastectomy, Modified) 10/2012